| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-09 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.33 | 2e-09 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.21 | 3e-09 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.22 | 5e-09 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.3 | 9e-09 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-08 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-08 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-08 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-08 |